Journal article · 2026 · Open access

Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death

Daniel J. de Klerk, Jiahao Tian, Gaoshuang Liu, Mladen Korbelik, David Kessel, Miroslav Chovanec, Yazan S. Khaled, Casper H.J. van Eijck, Lingfeng Wu, Michal Heger

Pharmacological Reviews, 100166 · Published 1 October 2026 · DOI 10.1016/j.pharmr.2026.100166

Open full textCite this paper

In brief

“Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death” is a 2026 journal article by Daniel J. de Klerk and 9 co-authors, published in Pharmacological Reviews. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at Pharmacological Reviews.

Citations
0
References
787
Authors
10

Abstract

Photodynamic therapy (PDT) produces spatially confined oxidative injury that can engage multiple regulated and accidental cell death programs with distinct immunological consequences. However, the strength of evidence supporting individual death modalities in PDT is highly uneven, and pathway assignment is frequently confounded by nonspecific biomarkers, incomplete causal validation, and extrapolation from non-PDT models. This review integrates the molecular biology of PDT-induced cell death with damage-associated molecular pattern signaling, antitumor immunity, therapeutic pharmacology, and clinical translation. A 14-parameter, mechanism-centered evidence appraisal framework was applied to the PDT literature to distinguish direct photodynamic evidence from mechanistic plausibility, model context, pharmacological and genetic validation, exclusion of competing pathways, temporal resolution, immune function, translational relevance, and overall confidence. On this basis, ferroptosis, intrinsic and extrinsic apoptosis, pyroptosis, necroptosis, and accidental necrosis emerge as the comparatively best-supported PDT-associated death modalities, whereas paraptosis, anoikis, autophagy-dependent cell death, cuproptosis, parthanatos, mitochondrial permeability transition-driven necrosis, and oxeiptosis remain emerging or insufficiently corroborated. The review further examines how photosensitizer localization, photodynamic exposure, oxygenation, tumor biology, and pharmacological intervention bias pathway engagement and shape immunogenicity, while emphasizing that damage-associated molecular pattern release does not by itself establish productive antitumor immunity. PDT-induced cell death is therefore mechanistically steerable in experimental systems but presently only potentially tunable in patients, where pathway-specific biomarker validation remains limited. Collectively, this framework provides the PDT field with an evidence-weighted basis for experimental design, pathway attribution, biomarker selection, pharmacological combination strategies, and mechanism-informed clinical investigation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

de Klerk, D. J., Tian, J., Liu, G., Korbelik, M., Kessel, D., Chovanec, M., Khaled, Y. S., van Eijck, C. H., Wu, L., & Heger, M. (2026). Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death. Pharmacological Reviews, 100166. https://doi.org/10.1016/j.pharmr.2026.100166

MLA 9

de Klerk, Daniel J., et al. “Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death.” Pharmacological Reviews, 2026, p. 100166. https://doi.org/10.1016/j.pharmr.2026.100166.

Chicago

de Klerk, Daniel J., Jiahao Tian, Gaoshuang Liu, Mladen Korbelik, David Kessel, Miroslav Chovanec, Yazan S. Khaled, Casper H.J. van Eijck, Lingfeng Wu, and Michal Heger. 2026. “Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death.” Pharmacological Reviews: 100166. https://doi.org/10.1016/j.pharmr.2026.100166.

Harvard

de Klerk, D. J. et al. (2026) ‘Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death’, Pharmacological Reviews, p. 100166. doi:10.1016/j.pharmr.2026.100166.

IEEE

D. J. de Klerk et al., “Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death,” Pharmacological Reviews, p. 100166, 2026, doi: 10.1016/j.pharmr.2026.100166.

BibTeX

@article{deklerk2026mechanisms,
  title     = {{Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death}},
  author    = {de Klerk, Daniel J. and Tian, Jiahao and Liu, Gaoshuang and Korbelik, Mladen and Kessel, David and Chovanec, Miroslav and Khaled, Yazan S. and van Eijck, Casper H.J. and Wu, Lingfeng and Heger, Michal},
  journal   = {Pharmacological Reviews},
  year      = {2026},
  pages     = {100166},
  doi       = {10.1016/j.pharmr.2026.100166},
  url       = {https://doi.org/10.1016/j.pharmr.2026.100166}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies

  • photodynamic therapy
  • cell death mechanisms
  • ferroptosis
  • apoptosis
  • pyroptosis
  • necroptosis
  • paraptosis
  • anoikis

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

de Klerk, D. J., Tian, J., Liu, G., Korbelik, M., Kessel, D., Chovanec, M., Khaled, Y. S., van Eijck, C. H., Wu, L., & Heger, M. (2026). Mechanisms and pharmacological modulation of photodynamic therapy-induced cell death. Pharmacological Reviews, 100166. https://doi.org/10.1016/j.pharmr.2026.100166

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmacological Reviews: sign in and open the full text from this page.

Who wrote this paper?

Daniel J. de Klerk, Jiahao Tian, Gaoshuang Liu, Mladen Korbelik, David Kessel, Miroslav Chovanec, Yazan S. Khaled, Casper H.J. van Eijck, Lingfeng Wu, Michal Heger.

What is the DOI of this paper?

10.1016/j.pharmr.2026.100166, permanently at https://doi.org/10.1016/j.pharmr.2026.100166. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.